Research on chronic inflammatory lung diseases
Official title: Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases: The RINNOPARI Project
Run by CHU de Reims · NCT02924818 · Data updated 2026-11-12
This study looks at people with chronic lung diseases to see how different factors relate to their conditions and help find better treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Status | Recruiting |
| Started | November 15, 2016 |
| Main results expected | November 2026 |
| Study ends | November 2036 |
| Registry record updated | February 24, 2025 |
| Trial ID | NCT02924818 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with COPD, cystic fibrosis, bronchiectasis, or interstitial lung diseases.
✕Probably not a fit
Patients under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on patients diagnosed with chronic inflammatory pulmonary diseases such as COPD, interstitial lung diseases, bronchiectasis, and cystic fibrosis. It aims to analyze various characteristics including clinical, demographic, biological, morphological, pathological, and microbiological features to better understand these conditions. By assessing the associations between these features, the study seeks to enhance the understanding of the diseases' pathophysiology and inform innovative treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients with chronic inflammatory lung diseases.
How similar studies have gone: Other studies have shown success in understanding chronic inflammatory diseases through similar comprehensive approaches, indicating potential for meaningful advancements.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (\>18 year-old) with COPD, CF, bronchiectasis or ILD Exclusion Criteria: * \<18 year-old
Where it's running
-
Chu Reims
Reims, France Recruiting
Study contacts
- Study coordinator: Gaëtan Deslée
- Email: gdeslee@chu-reims.fr
- Phone: 326787611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does the order of endurance and strength training in COPD rehab matter for muscle strength?
This study tests whether doing strength training before endurance training during pulmonary rehab improves muscle strength in adults with COPD.
-
Right ventricular–arterial coupling during fluid loading in ICU patients
This study tests how the right ventricle handles fluid changes in critically ill adults to see how it affects blood flow and congestion.
-
Social cognition in severe alcohol use disorder
This study tests how social-cognition abilities relate to brain structure in adults with severe alcohol use disorder who are abstinent and receiving care.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Antiphospholipid syndrome in people 65 and older who had an ischemic stroke
This study will test whether routine blood testing for antiphospholipid antibodies in people aged 65 and over hospitalized with ischemic stroke or TIA can identify previously unrecognized antiphospholipid syndrome.
-
French translation and validation of the mPCOSQ quality-of-life questionnaire for women with PCOS.
This project tests a French version of the mPCOSQ to see if it reliably measures health-related quality of life in French-speaking women with PCOS aged 18–45.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.